(Q37149383)

18 August 2017

A controlled clinical study of chlorpromazine and reserpine in chronic schizophrenia (English)

1 reference

18 August 2017

0 references

chronic schizophrenia

1 reference

1 reference

SHEPHERD M

1

1 reference

PMCID

497211

18 August 2017

WATT DC

series ordinal

2

1 reference

PMCID

497211

18 August 2017

language of work or name

English

0 references

publication date

1 August 1956

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

18 August 2017

1 reference

18 August 2017

19

1 reference

18 August 2017

232-235

1 reference

18 August 2017

3

1 reference

Rauwolfia serpentina (serpasil) in psychiatry

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=497211

Complications of chlorpromazine therapy in 800 mental-hospital patients.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=497211

Chlorpromazine in psychiatry.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=497211

Chlorpromazine and reserpine in the treatment of psychoses

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=497211

The control of deviant behavior in chronically disturbed psychotic patients by the oral administration of reserpine.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=497211

Treatment of two hundred disturbed psychotics with reserpine.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=497211

Reserpine (serpasil) in the management of the mentally ill

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=497211

Reserpine in treatment of chronic psychotics; preliminary observations.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=497211

Preliminary observations on the psychiatric uses of chlorpromazine (largactil).

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=497211

[Largactil therapy in schizophrenia and other psychotic conditions]

3 September 2018

1 reference

12 December 2020

An evaluation of chlorpromazine ("largacill") in psychiatry

1 reference

12 December 2020

Treatment of psychotic states with chlorpromazine

1 reference

12 December 2020

The use of reserpine in shock-reversible patients and shock-resistant patients

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.19.3.232

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

PMCID

497211